Table 2 |
|||
|
Sources and dilutions of primary antibodies used in this study |
|||
| Antibody |
Clone |
Manufacturer |
Dilution |
|
|
|||
| ER |
1D5 |
Dako |
1:200 |
| PR |
PgR 636 |
Dako |
1:50 |
| HER2 |
A0485 (rabbit polyclonal) |
Dako |
1:400 |
| CK5/6 |
D5/16B4 |
Dako |
1:50 |
| EGFR |
2-18C9 |
Dako |
pre-diluted (pharmDX kit) |
|
|
|||
|
CK5/6, cytokeratin 5/6; EGFR, epidermal growth factor receptor; ER, oestrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2. |
|||
|
Tamimi et al. Breast Cancer Research 2008 10:R67 doi:10.1186/bcr2128 |
|||
